Mary Banoub, PharmD, BCIDP, CPP

Atrium Health Wake Forest Baptist Medical Center

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-421) Impact of Rapid Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Screening on Duration of Vancomycin (Vanc) Therapy for Suspected Pneumonia (PNA) in Adult Patients (Pts) Admitted to the Trauma Intensive Care Unit (TICU)
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-859) Shorter versus Longer Duration of Antibiotic Therapy for Gram-Negative Bacteremia (GNB) in Immunocompromised Patients
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1525) Real-World Efficacy of Fosfomycin for Treatment of Cystitis Caused by E. coli Versus Non-E. coli Gram Negatives With High Rates of FosA
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1675) Antibiotic Inertia Occurs Frequently in Patients Admitted from the Emergency Department on Guideline Non-Concordant Therapy
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT